Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidylprolyl isomerase E like (PPIEL) is a transcribed pseudogene in humans, closely related in DNA sequence to the functional Peptidylprolyl isomerase E (PPIE) gene. While PPIE is an active cyclophilin involved in protein folding and immune regulation[1][7], PPIEL is not translated into a functional protein, does not participate in catalysis, and is therefore not considered a therapeutic target. However, differential expression or DNA methylation at the PPIEL locus has been observed in some diseases, suggesting possible biomarker value, though its mechanistic significance remains unclear[9][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase E like pseudogene (PPIEL).